As a CRO we have the opportunity to work with a large variety of analytes, from small polar molecules to peptides, proteins, nanoparticles and oligonucleotides. This broad range of analytes and our involvement in a large variety of programme designs, from early-stage pre-clinical investigative work to in-vitro biosimilar evaluation and clinical trials, means that we are always expanding our knowledge and skills. As well as our ever-evolving workflow, our consistent involvement with the industry through conferences, literature, and multi-company project teams, provide additional opportunities for development of both the industry and individuals.